Longevity biotechnology firm, Genflow Biosciences announces IPO on LSE
LONDON, UK: Genflow Biosciences, a UK-based biotechnology company focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with advanced age, has announced intention to seek a listing of its ordinary shares to…